Moxetumomab pasudotox and Sitagliptin and metformin
Determining the interaction of Moxetumomab pasudotox and Sitagliptin and metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: metformin / sitagliptin
Brand name: Janumet, Janumet XR
Synonyms: Metformin and sitagliptin, Sitagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Sitagliptin and Metformin Extended-Release Tablets
- Moxetumomab pasudotox-Sitagliptin and Metformin Tablets
- Moxetumomab pasudotox-Sitagliptin and simvastatin
- Moxetumomab pasudotox-Sitagliptin Phosphate
- Moxetumomab pasudotox-Sitavig
- Moxetumomab pasudotox-Sivextro
- Sitagliptin and metformin-Moxetumomab Pasudotox-tdfk
- Sitagliptin and metformin-Moxetumomab pasudotox-tdfk Intravenous
- Sitagliptin and metformin-Moxifloxacin
- Sitagliptin and metformin-Moxifloxacin (Systemic)
- Sitagliptin and metformin-Moxifloxacin Hydrochloride
- Sitagliptin and metformin-Moxifloxacin Injection